Andrea Aramini

R&d
Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat (Diabetes Metab J 2025;49:990-1005).

Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat (Diabetes Metab J 2025;49:990-1005).

Journal: Diabetes & metabolism journal

Published: May 13, 2026

Refining free fatty acid receptor agonism for metabolic control: Pharmacological and functional features of novel dual GPR40/GPR120 ligands.

Refining free fatty acid receptor agonism for metabolic control: Pharmacological and functional features of novel dual GPR40/GPR120 ligands.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 15, 2026

CXCL8 greatly enhances neutrophil extracellular traps formation induced by calcium crystals in vitro and in vivo.

CXCL8 greatly enhances neutrophil extracellular traps formation induced by calcium crystals in vitro and in vivo.

Journal: Frontiers in pharmacology

Published: January 23, 2026

Towards greener-by-design fine chemicals. Part 2: technological frontiers.

Towards greener-by-design fine chemicals. Part 2: technological frontiers.

Journal: Chemical Society reviews

Published: November 20, 2025

CXCR2 antagonism as a promising therapeutic approach for pulmonary fibrosis therapy.

CXCR2 antagonism as a promising therapeutic approach for pulmonary fibrosis therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 17, 2025

Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat (Diabetes Metab J 2025;49:990-1005).

Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat (Diabetes Metab J 2025;49:990-1005).

Journal: Diabetes & metabolism journal

Published: November 17, 2025

Ladarixin Potential over the Effects of IL-8 and of Serum from Patients with Abdominal Aortic Aneurysm on Human Aortic Cells.

Ladarixin Potential over the Effects of IL-8 and of Serum from Patients with Abdominal Aortic Aneurysm on Human Aortic Cells.

Journal: Cells

Published: September 26, 2025

Deep Supramolecular Language Processing for Co-Crystal Prediction.

Deep Supramolecular Language Processing for Co-Crystal Prediction.

Journal: Angewandte Chemie (International ed. in English)

Published: April 09, 2025

The dual non-competitive CXCR1/2 inhibitor ladarixin impairs neutrophil extravasation without altering intravascular adhesion.

The dual non-competitive CXCR1/2 inhibitor ladarixin impairs neutrophil extravasation without altering intravascular adhesion.

Journal: Haematologica

Published: March 20, 2025

Spontaneous flow in active nematics: Effects induced by annular confinement.

Spontaneous flow in active nematics: Effects induced by annular confinement.

Journal: Physical review. E

Published: March 12, 2025

Evaluation of the gastrotolerability of ketoprofen, lysine, and gabapentin co-crystal administration in an in vitro model of gastric epithelium: a proteomic update.

Evaluation of the gastrotolerability of ketoprofen, lysine, and gabapentin co-crystal administration in an in vitro model of gastric epithelium: a proteomic update.

Journal: PloS one

Published: March 06, 2025

A novel free fatty acid receptor agonist improving metabolic health in Drosophila models.

A novel free fatty acid receptor agonist improving metabolic health in Drosophila models.

Journal: Pharmacological research

Published: February 26, 2025

Showing 1-12 of 55

Last Updated: 09/26/2026